Remarkably, HO-1 induction mediates cancer cell resistance not only to chemotherapeutic agents but also to radio-, photodynamic-, and non-thermal-plasma (NTP) therapies, as demonstrated in non-small cell lung carcinoma [152,153,154]. This evidence concerns the gene HMOX1 and cancer.